case 4: chemotherapy or parp inhibitors for brca tnbc
Published 4 years ago • 147 plays • Length 8:50Download video MP4
Download video MP3
Similar videos
-
3:46
case 4: parp inhibitors for treating brca triple-negative breast cancer
-
5:40
case 4: looking forward in brca metastatic tnbc
-
5:38
case 4: olympiad trial for brca metastatic tnbc
-
4:01
case 4: brca metastatic breast cancer
-
8:04
chemotherapy and parp inhibitors in bc
-
1:13
addressing the role of parp inhibitors in different breast cancer settings
-
5:19
parp inhibitors for brca-associated tnbc
-
3:41
case 2: treating brca-mutated ovarian cancer
-
5:18
parp inhibitors for brca-mutated tnbc
-
1:46
combination of veliparib and chemotherapy in brca-positive breast cancer
-
1:39:18
expanding the benefits of checkpoint inhibitors and targeted agents in triple-negative breast cancer
-
4:40
case 3: the use of combination therapy in triple-negative breast cancer
-
6:05
mechanisms of resistance to parp inhibitor or platinum chemotherapy in brca1/2 mutated metastati...
-
1:10
managing metastatic breast cancer and beyond using parp inhibitors
-
6:20
parp inhibitors for brca-mutated tnbc
-
2:08
dr. lorusso on parp inhibitors in triple-negative breast cancer
-
6:08
role of parp inhibition and i/o therapy in tnbc
-
3:50
clinical approach to triple-negative breast cancer
-
1:41
parp inhibitors are a promising alternative to chemotherapy for patients with metastatic brca1 a...